Children diagnosed with juvenile idiopathic arthritis (JIA) have triple the risk for cancer, and the findings hold for those who were never treated with biologic therapies for JIA, according to a new study.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.